Good News 
University of Oxford and Moderna to trial cancer prevention vaccine for Lynch syndrome patients
A new mRNA vaccine designed to help the immune system identify and eliminate pre-cancerous cells in people with Lynch syndrome is set for i…
Newcastle clinical trial investigates psilocybin as a treatment for resistant depression
Dr Mourad Wahba is leading a phase three clinical trial in Newcastle to test the efficacy of synthetic psilocybin for patients with treatme…
Cardiff University launches first study into head injuries in female rugby players
Twenty-two-year-old Ffion Jones is one of 30 women participating in a Cardiff University study examining the effects of repeated head impac…
NHS hospitals adopt non-invasive urine test for bladder cancer
Five NHS hospitals have begun using a DNA-based urine test for bladder cancer, replacing the traditional, invasive cystoscopy procedure. By…
New triple-action diabetes injection shows promise in reducing blood sugar and body weight
A phase 3 trial has found that a weekly injection called retatrutide helps manage type 2 diabetes by mimicking three gut hormones to contro…
New experimental drug helps immunotherapy target cancer cells by removing their 'invisibility cloaks'
Researchers have developed a tablet that prevents cancer cells from hiding from the immune system, allowing existing treatments to detect a…
University of Cambridge researchers develop AI-designed vaccine
Researchers at the University of Cambridge have used artificial intelligence to create a new type of vaccine capable of protecting against …
Laura Tobin receives Royal Meteorological Society award
Good Morning Britain weather presenter Laura Tobin has been honoured with the Michael Hunt Award. The Royal Meteorological Society presente…
NHS England approves new treatment for advanced ovarian cancer
Hundreds of women with chemotherapy-resistant ovarian cancer will now have access to a new life-prolonging drug called Elahere. This marks …
Immunotherapy drug reduces need for bladder removal surgery
A new clinical trial has shown that adding the drug durvalumab to standard cancer treatments can effectively destroy bladder tumours. This …
Hospital scientist retires after 45-year career in Kent
Shirley Moses has retired from the William Harvey Hospital in Ashford after an impressive 45-year career in biomedical science. She spent d…
British Paralympian John McFall to train for space mission
British Paralympian and surgeon John McFall is set to become the first astronaut with a physical disability to live in orbit. He will trave…